Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “testosterone” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 10
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 10 pipeline programs matching "testosterone" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

10 results for “testosterone” Back to intelligence hub

Search results

  1. Testosterone Gel 1% for low ovarian reserve according t…

    The George Institute

    low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism

    phase 3 small molecule active

    1 trial
  2. Testosterone MD-Lotion

    Eli Lilly and Company

    Hypogonadism

    phase 3 small molecule completed

    1 trial
  3. Testosterone Topical Gel, 1.62% Metered Pump

    Amneal Pharma Europe Ltd

    Primary Hypogonadism

    phase 3 small molecule completed

    1 trial
  4. Testosterone Transdermal System

    Warner Chilcott Deutschland GmbH

    Hypoactive Sexual Desire Disorder

    phase 3 small molecule completed

    1 trial
  5. Testosterone enanthate

    HALOZYME THERAPEUTICS, INC.

    Hypogonadism, Male

    phase 3 other active

    1 trial
  6. TAK-448

    Takeda

    Low Testosterone

    phase 2 small molecule terminated

    1 trial
  7. Testosterone Enanthate 100 MG/ML Injectable Solution

    Hospital Authority, Hong Kong

    Castration-resistant Prostate Cancer

    phase 2 small molecule active

    1 trial
  8. Testosterone Gel applied by a pump

    United Therapeutics Europe Ltd

    Spinal Cord Injury

    phase 2 small molecule active

    1 trial
  9. Testosterone cypionate

    United Therapeutics Europe Ltd

    Castration Resistant Metastatic Prostate Cancer

    phase 2 small molecule completed

    1 trial
  10. Bioequivalence of Testosterone Transdermal Gel in Healthy Female Participants.

    Laboratorios Tillomed Spain S.L.U

    No medical conditions.

    phase 1 other active

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.